Psoriasis: A STAT3-Centric View

International Journal of Molecular Sciences
Enzo CalauttiValeria Poli

Abstract

Signal Transducer and Activator of Transcription (STAT)3 has recently emerged as a key player in the development and pathogenesis of psoriasis and psoriatic-like inflammatory conditions. Indeed, STAT3 hyperactivation has been reported in virtually every cell type involved in disease initiation and maintenance, and this factor mediates the signal of most cytokines that are involved in disease pathogenesis, including the central Interleukin (IL)-23/IL-17/IL-22 axis. Despite the recent availability of effective biological agents (monoclonal antibodies) against IL-17 and IL-23, which have radically changed the current standard of disease management, the possibility of targeting either STAT3 itself or, even better, the family of upstream activators Janus kinases (JAK1, 2, 3, and TYK2) offers additional therapeutic options. Due to the oral/topical administration modality of these small molecule drugs, their lower cost, and the reduced risk of eliciting adverse immune responses, these compounds are being actively scrutinized in clinical settings. Here, we summarize the main pathological features of psoriatic conditions that provide the rationale for targeting the JAK/STAT3 axis in disease treatment.

References

Sep 1, 1985·Journal of the American Academy of Dermatology·T Henseler, E Christophers
Jan 1, 1983·Archives of Dermatological Research·J D BosR H Cormane
Feb 1, 1980·The British Journal of Dermatology·A TiilikainenM Julin
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·J C ChangD J Carlo
Oct 1, 1996·The Journal of Investigative Dermatology·M KomineM Blumenberg
Aug 26, 1998·The Biochemical Journal·P C HeinrichL Graeve
Jun 26, 2001·Clinical and Experimental Dermatology·E Christophers
Jan 5, 2002·The Journal of Biological Chemistry·Sandrine GiraudOlivier Coqueret
May 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christi ParhamKevin W Moore
Aug 9, 2003·Nuclear Receptor·Fernando De MiguelAllen C Gao
Dec 10, 2003·The Journal of Experimental Medicine·Craig A MurphyDaniel J Cua
Dec 18, 2003·Clinical and Experimental Immunology·J E GudjonssonH Valdimarsson
May 4, 2004·International Immunopharmacology·Marehalli L NagalakshmiRene de Waal Malefyt
Jan 20, 2005·The Journal of Experimental Medicine·Claire L LangrishDaniel J Cua
Mar 30, 2005·Journal of Dermatological Science·Z ShenY-F Liu
Apr 28, 2006·American Journal of Human Genetics·Rajan P NairJames T Elder
May 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Zhi ChenJohn J O'Shea
Oct 14, 2006·European Journal of Immunology·Ivo SondereggerManfred Kopf
Jan 20, 2007·Blood·Rong ZengWarren J Leonard
Feb 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Susan M SaWenjun Ouyang
Feb 6, 2007·The Journal of Biological Chemistry·Xuexian O YangChen Dong
Sep 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Timothy J HarrisCharles G Drake
Sep 21, 2007·The New England Journal of Medicine·Steven M HollandBodo Grimbacher
Dec 19, 2007·Archives of Dermatology·Joel M GelfandBrian L Strom
Jul 2, 2008·The Journal of Experimental Medicine·Cindy S MaMatthew C Cook
Jul 18, 2008·The Journal of Investigative Dermatology·Lisa C ZabaMichelle A Lowes
Mar 14, 2009·Proceedings of the National Academy of Sciences of the United States of America·Francesco VallaniaValeria Poli
Mar 20, 2009·The Journal of Investigative Dermatology·Erin G HarperAndrew Blauvelt
Mar 31, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Kerstin WolkRobert Sabat
Aug 4, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wendy A GoodmanKevin D Cooper
Aug 18, 2009·Nature Medicine·Roberta CarusoGiovanni Monteleone
Aug 26, 2009·The Journal of Experimental Medicine·Dipyaman GangulyMichel Gilliet
Sep 3, 2009·Annals of the New York Academy of Sciences·Bharat B AggarwalBokyung Sung
Sep 29, 2009·Trends in Immunology·Helgi ValdimarssonAndrew Johnston
Nov 10, 2009·The Journal of Allergy and Clinical Immunology·Lisa C ZabaJames G Krueger

❮ Previous
Next ❯

Citations

Mar 21, 2020·Expert Opinion on Emerging Drugs·Esther A BaloghSteven R Feldman
Jul 24, 2020·The Journal of Clinical Investigation·Anne MüllerDaniela Kramer
Aug 23, 2020·Pharmaceutics·Mehwish JabeenMyriam Lamrayah
Feb 20, 2020·International Journal of Molecular Sciences·Masutaka FurueTakeshi Nakahara
Mar 17, 2020·Archives of Dermatological Research·Cervantes-Durán ClaudiaGarcía-Pérez Martha-Estrella
Sep 29, 2020·Frontiers in Cell and Developmental Biology·Lin GongXuegang Xu
Jan 31, 2019·Development·Salvador C Herrera, Erika A Bach
Sep 21, 2018·International Journal of Molecular Sciences·Ilenia SegattoBarbara Belletti
Oct 4, 2020·Lipids in Health and Disease·Klaudia DopytalskaIrena Walecka
Jan 2, 2021·Journal of Personalized Medicine·Dmitry A VerbenkoAlexey A Kubanov
Feb 19, 2021·Frontiers in Immunology·Xin SuDong Chang
Jul 28, 2020·Trends in Immunology·Martin VaethStefan Feske
Jul 9, 2021·Psoriasis : Targets and Therapy·Hakim Ben AbdallahLars Iversen
Aug 7, 2021·Redox Report : Communications in Free Radical Research·Dehai XianJianqiao Zhong
Aug 28, 2021·International Journal of Molecular Sciences·Vladimir SobolevIrina Korsunskaya
Aug 8, 2021·British Journal of Pharmacology·Lihua HaoByung-Hyun Park

❮ Previous
Next ❯

Related Concepts

Related Feeds